DUBLIN--(BUSINESS WIRE)--The "2022 U.S MR (Magnetic Resonance) Market Outlook Report" report has been added to ResearchAndMarkets.com's offering.
This 2022 MR Market Outlook Report summarizes the results of the analyst's 2022 survey of U.S. hospitals and independent imaging centers that perform MR procedures using fixed and mobile MR scanners and provides a summary of the MR medical imaging market. The report provides detailed information about the priorities and outlook of departments with MR scanners, information about procedure volumes and the mix of procedures performed using MR systems.
The report also covers installed base information and future purchase plans, including information about which manufacturers are present and being considered for purchase over the next few years. In addition, the report covers installed base and purchase plan information for MR contrast media and power injectors.
The report includes detailed information about the departments in the hospital where the equipment is currently located including in the main radiology department and outpatient departments. The report includes a wide variety of charts and graphs that breakout the above information along a number of dimensions including department type and hospital size. The key features and findings of these charts are highlighted in the report and where appropriate comparisons to previous data are noted for context.
Respondents participated in an online survey from July 15 to August 26, 2022. To monitor key industry trends, results from this 2022 MR Market Outlook Report are compared to previous MR market reports.
Three-quarters of MR sites in the U.S. anticipate that their 2022 procedure volume will be higher in 2022 than in 2021, according to the analyst’s 2022 MR Market Outlook Report. And that growth will be achieved across all site types.
Independent imaging centers are most optimistic about procedure volumes increasing, with 80% anticipating growth. Meanwhile, midsized, 200-399 bed hospitals are comparatively least optimistic at 70%, although this is still a very optimistic level.
At the time of the 2022 survey, 53% of MR sites were considering the purchase of a new scanner between 2022 and 2025. Compared with the 2021 survey, purchase consideration (“yes” and “maybe”) increased by 3 percentage points to 53% of sites.
According to the survey, the top 5 priorities and outlook factors for MR departments are:
- “Improve patient satisfaction with their MR experience.”
- “Satisfy the needs of referring physicians.”
- “Improve staff satisfaction and morale.”
- “Improve MR department workflow and productivity.”
- “Reduce patient backlog and waiting time.”
Reducing patient backlog and waiting time was a new addition to the list of top 5 priorities and outlook factors.
In notable trends, artificial intelligence (AI) is being used in MR to improve image quality and improve workflows. The #1 ranked use of AI in MR departments is to improve image quality output, with 50% of respondents ranking #1 or #2. The #2 ranked use of AI/machine-learning capabilities - with 44% of respondents ranking #1 or #2 - is to help the department’s workflow from image acquisition to providing images to the radiologists.
The impact of the COVID-19 pandemic on MR departments peaked in 2021 and is now at the lowest level since 2020. The peak impact occurred in 2021 with 65% of departments experiencing a medium or high impact from the pandemic, with an average rating of 6.9 out of 10, with 10 being the highest impact. In the summer of 2022, 24% of sites continued to experience a medium or high impact with an average rating of 4.2 out of 10.
As of this 2022 survey, GE HealthCare and Siemens Healthineers together comprise 74% of the MR installed base, with 37% installed base share each, followed by Philips with 11% and Fujifilm Medical Systems and Canon Medical Systems with 7% each.
Looking at the MR power injectors installed as of this 2022 survey, Bayer is the leader, with 74% of the installed units. Guerbet accounts for 13%, followed closely by Bracco Diagnostics with 13%.
With lots of recent advances in MR scanner technology, this is an interesting segment to watch for the next few years.
The 2022 MR Market Outlook Report explores market trends in U.S. hospitals and imaging centers, including procedure volume, manufacture-installed base features and share, the use of OEM vs. third-party service providers, purchase plans, brand loyalty, and site operations characteristics.
The MR Market Outlook Report was published in December 2022 and is based on responses from 300 radiology/departmental administrators and clinicians who participated in the nationwide survey in July-August 2022. Their responses have been projected to the identified universe of hospitals and imaging centers in the U.S. that use MR systems to perform imaging procedures, and the report provides market forecast information addressing the MR unit market in the United States for 2022-2025. Vendors covered in this report include GE, Philips, Siemens, Canon, Fujifilm, Bayer, Bracco, Guerbet and more.
Key topics include:
- MR Priorities & Outlook
- Trends on MR Procedure Volume and Mix
- Installed Base of MR Scanners
- MR Purchase Plans
- MR Contrast Media & Power Injectors
- Demographics & Site Operations Characteristics
This report is ideal for anyone interested in learning more about how advancements in MR imaging are impacting the medical diagnostic imaging market.
It is a great resource for:
- Marketing Managers
- Product Managers
- Marketing Directors
- Sales Managers
- Analysts
That work in diagnostic imaging equipment manufacturing, hospital and healthcare systems, consulting, investment and finance industries. This report is a great way to get a quick overview of recent developments and help to plan for what lies ahead.
A selection of companies mentioned in this report includes
- Bayer
- Bracco
- Canon Medical Systems
- Fujifilm Medical Systems
- GE HealthCare
- Guerbet
- Philips
- Siemens Healthineers
For more information about this report visit https://www.researchandmarkets.com/r/b76cpp
